Literature DB >> 29228122

Tennessee's In-state Vulnerability Assessment for a "Rapid Dissemination of Human Immunodeficiency Virus or Hepatitis C Virus Infection" Event Utilizing Data About the Opioid Epidemic.

Michael Rickles1, Peter F Rebeiro2, Lindsey Sizemore1, Paul Juarez3, Mitchell Mutter1, Carolyn Wester1, Melissa McPheeters1.   

Abstract

Background: Knowing which factors contribute to county-level vulnerability to a human immunodeficiency virus (HIV)/hepatitis C virus (HCV) outbreak, and which counties are most vulnerable, guides public health and clinical interventions. We therefore examined the impact of locally available indicators related to the opioid epidemic on prior national models of HIV/HCV outbreak vulnerability.
Methods: Tennessee's 95 counties were the study sample. Predictors from 2012 and 2013 were used, mirroring prior methodology from the US Centers for Disease Control and Prevention (CDC). Acute HCV incidence was the proxy measure of county-level vulnerability. Seventy-eight predictors were identified as potentially predictive for HIV/HCV vulnerability. We used multiple dimension reduction techniques to determine predictors for inclusion and Poisson regression to generate a composite index score ranking county-level vulnerability for HIV/HCV.
Results: There was overlap of high-risk counties with the national analysis (25 of 41 counties). The distribution of vulnerability reinforces earlier research indicating that eastern Tennessee is at particularly high risk but also demonstrates that the entire state has high vulnerability. Conclusions: Prior research placed Tennessee among the top states for opioid prescribing, acute HCV infection, and greatest risk for an HIV/HCV outbreak. Given this confluence of risk, the Tennessee Department of Health expanded upon prior work to include more granular, local data, including on opioid prescribing. We also explored nonfatal and fatal overdoses. The more complete statewide view of risk generated, not only in eastern counties but also in the western corridor, will enable local officials to monitor vulnerability and better target resources.

Entities:  

Mesh:

Year:  2018        PMID: 29228122      PMCID: PMC5961330          DOI: 10.1093/cid/cix1079

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Very Simple Structure: An Alternative Procedure For Estimating The Optimal Number Of Interpretable Factors.

Authors:  W Revelle; T Rocklin
Journal:  Multivariate Behav Res       Date:  1979-10-01       Impact factor: 5.923

2.  Increased use of heroin as an initiating opioid of abuse.

Authors:  Theodore J Cicero; Matthew S Ellis; Zachary A Kasper
Journal:  Addict Behav       Date:  2017-05-23       Impact factor: 3.913

3.  County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

Authors:  Michelle M Van Handel; Charles E Rose; Elaine J Hallisey; Jessica L Kolling; Jon E Zibbell; Brian Lewis; Michele K Bohm; Christopher M Jones; Barry E Flanagan; Azfar-E-Alam Siddiqi; Kashif Iqbal; Andrew L Dent; Jonathan H Mermin; Eugene McCray; John W Ward; John T Brooks
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

4.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

5.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.

Authors:  Philip J Peters; Pamela Pontones; Karen W Hoover; Monita R Patel; Romeo R Galang; Jessica Shields; Sara J Blosser; Michael W Spiller; Brittany Combs; William M Switzer; Caitlin Conrad; Jessica Gentry; Yury Khudyakov; Dorothy Waterhouse; S Michele Owen; Erika Chapman; Jeremy C Roseberry; Veronica McCants; Paul J Weidle; Dita Broz; Taraz Samandari; Jonathan Mermin; Jennifer Walthall; John T Brooks; Joan M Duwve
Journal:  N Engl J Med       Date:  2016-07-21       Impact factor: 91.245

6.  The changing face of heroin use in the United States: a retrospective analysis of the past 50 years.

Authors:  Theodore J Cicero; Matthew S Ellis; Hilary L Surratt; Steven P Kurtz
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

7.  Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.

Authors:  Gery P Guy; Kun Zhang; Michele K Bohm; Jan Losby; Brian Lewis; Randall Young; Louise B Murphy; Deborah Dowell
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-07-07       Impact factor: 17.586

8.  Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

Authors:  Jon E Zibbell; Kashif Iqbal; Rajiv C Patel; Anil Suryaprasad; Kathy J Sanders; Loretta Moore-Moravian; Jamie Serrecchia; Steven Blankenship; John W Ward; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

  8 in total
  14 in total

Review 1.  The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions.

Authors:  David C Perlman; Ashly E Jordan
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

2.  Surveillance, Epidemiology, and Estimated Burden of Neonatal Abstinence Syndrome, Tennessee, 2013-2016.

Authors:  Julia Brennan; Caleb Wiedeman; John R Dunn; William Schaffner; Timothy F Jones
Journal:  Public Health Rep       Date:  2019-08-07       Impact factor: 2.792

3.  Injection and Sexual Behavior Profiles among People Who Inject Drugs in Miami, Florida.

Authors:  Teresa A Chueng; Hansel E Tookes; Megan McLaughlin; Angela M Arcaro-Vinas; David P Serota; Tyler S Bartholomew
Journal:  Subst Use Misuse       Date:  2022-06-10       Impact factor: 2.362

4.  Hepatitis C Coinfection and Mortality in People Living with HIV in Middle Tennessee.

Authors:  Toni Hall; Cathy A Jenkins; Todd Hulgan; Sally Furukawa; Megan Turner; Siddharth Pratap; Timothy R Sterling; Mohammad Tabatabai; Vladimir Berthaud
Journal:  AIDS Res Hum Retroviruses       Date:  2019-12-30       Impact factor: 2.205

5.  HIV-1 Transmission Clustering and Phylodynamics Highlight the Important Role of Young Men Who Have Sex with Men.

Authors:  Ann M Dennis; Erik Volz; A S Md Simon D W Frost; Mukarram Hossain; Art F Y Poon; Peter F Rebeiro; Sten H Vermund; Timothy R Sterling; Marcia L Kalish
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-23       Impact factor: 2.205

6.  Risk factors associated with infection of blood-borne virus among people who used methamphetamine.

Authors:  Yilin Cai; Zheng Dai; Sijin Wen; Ruchi Bhandari
Journal:  BMC Infect Dis       Date:  2020-10-09       Impact factor: 3.090

7.  Ensemble learning to predict opioid-related overdose using statewide prescription drug monitoring program and hospital discharge data in the state of Tennessee.

Authors:  Michael Ripperger; Sarah C Lotspeich; Drew Wilimitis; Carrie E Fry; Allison Roberts; Matthew Lenert; Charlotte Cherry; Sanura Latham; Katelyn Robinson; Qingxia Chen; Melissa L McPheeters; Ben Tyndall; Colin G Walsh
Journal:  J Am Med Inform Assoc       Date:  2021-12-28       Impact factor: 7.942

8.  Identifying counties at risk of high overdose mortality burden during the emerging fentanyl epidemic in the USA: a predictive statistical modelling study.

Authors:  Charles Marks; Daniela Abramovitz; Christl A Donnelly; Gabriel Carrasco-Escobar; Rocío Carrasco-Hernández; Daniel Ciccarone; Arturo González-Izquierdo; Natasha K Martin; Steffanie A Strathdee; Davey M Smith; Annick Bórquez
Journal:  Lancet Public Health       Date:  2021-06-10

9.  A Vulnerability Assessment for a Future HIV Outbreak Associated With Injection Drug Use in Illinois, 2017-2018.

Authors:  Cara Jane Bergo; Jennifer R Epstein; Stacey Hoferka; Marynia Aniela Kolak; Mai T Pho
Journal:  Front Sociol       Date:  2021-05-19

10.  Machine learning takes a village: Assessing neighbourhood-level vulnerability for an overdose and infectious disease outbreak.

Authors:  Jesse L Yedinak; Yu Li; Maxwell S Krieger; Katharine Howe; Colleen Daley Ndoye; Hyunjoon Lee; Anna M Civitarese; Theodore Marak; Elana Nelson; Elizabeth A Samuels; Philip A Chan; Thomas Bertrand; Brandon D L Marshall
Journal:  Int J Drug Policy       Date:  2021-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.